Summary
- Current Price
- As of today, TEM price is $64.72, down -9.01% on
- Current Price All-Time High
- TEM price is currently -37.96% below its historical high of $104.32 set on
- Market Cap
- TEM current market cap is $12B, down -27.79% year-over-year
- Revenue
- TEM current annual revenue is $1.27B, up +83.41% year-over-year
- Next Earnings
- The next earnings release for TEM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Tempus AI, Inc. |
| Ticker | NASDAQ: TEM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tempus.com |
| Employees | 2,400 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $64.72 | |
| Price, 1D Change | -9.01% | |
| Market Cap | $12B | |
| - | ||
| PE Ratio | - | |
| Beta | 2.56 | |
| Revenue | $1.27B | |
| Revenue, 1Y Change | +83.41% | |
| EPS | -$1.41 | |
| EPS, 1Y Change | +69.46% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$1.41 | |
| EPS Estimate | -$0.25 | N/A |
| EPS Est. Change | +82.07% | N/A |
| Revenue | $1.27B | |
| Revenue Estimate | $1.60B | N/A |
| Revenue Est. Change | +25.43% | N/A |
| Current Price | $64.72 | |
| Price Target | $75.00 | - |
| Price Tgt. Change | +15.88% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.78 | -$4.60 | -157.97% | |
| -$0.62 | -$1.41 | -126.43% | |
| -$0.25 | N/A | +82.07% | |
| -$0.05 | N/A | +96.65% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $695.53M | $693.40M | -0.31% | |
| $1.27B | $1.27B | +0.28% | |
| $1.60B | N/A | +25.43% | |
| $1.97B | N/A | +54.83% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -28.89% | |
| Price, 3Y | - | |
| Market Cap, 1Y | -27.79% | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | +83.41% | |
| Revenue, 3Y | +296.61% | |
| EPS, 1Y | +69.46% | |
| EPS, 3Y | +28.47% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $64.72 | |
| SMA 200 | $56.79 | |
| SMA 50 | $67.82 | |
| EMA 200 | $60.73 | |
| EMA 50 | $67.88 | |
| MACD | -$0.36 | |
| Beta | 2.56 | |
| ATR | $5.77 | |
| 14-Day RSI | 41.50 | |
| 10-Day Volatility | 103.15% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $1.27B | |
| EPS | -$1.41 | |
| Gross Profit | $781.59M | |
| Gross Margin | 61.46% | |
| Operating Income | -$238.64M | |
| Operating Margin | -18.76% | |
| Net Income | -$245.03M | |
| Net Margin | -19.27% | |
| EBITDA | -$136.31M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 2.70 | |
| 3.13 | ||
| 3.00 | ||
| - | ||
| 3 | ||
| 3.09 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 8.15 | ||
| 26.25 | ||
| -74.66 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $491.33M | |
| $755.00M | ||
| $2.27B | ||
| $1.17B | ||
| $1.78B | ||
| $372.39M | ||
| Total Debt | $1.33B | |
| $13.36M | ||
| $81.99M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.52B | ||
| $1.02B | ||
| $490.20M | ||
| $0.00 | ||
| $102.32M | ||
| $0.00 | ||
| -$51.68M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$218.09M | ||
| -$398.36M | ||
| $884.12M | ||
| Capex | $27.27M | |
| -$245.36M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| JP Morgan | → | |
| Canaccord Genuity | → | |
| Guggenheim | → | |
| Goldman Sachs | ||
| HC Wainwright & Co. | → | |
| UBS | ||
| Rothschild & Co | ||
| Roth Capital | ||
| Cantor Fitzgerald | ||
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with TEM
FAQ
- What is the ticker symbol for Tempus AI, Inc.?
- The ticker symbol for Tempus AI, Inc. is NASDAQ:TEM
- Does Tempus AI, Inc. pay dividends?
- No, Tempus AI, Inc. does not pay dividends
- What sector is Tempus AI, Inc. in?
- Tempus AI, Inc. is in the Healthcare sector
- What industry is Tempus AI, Inc. in?
- Tempus AI, Inc. is in the Health Information Services industry
- What country is Tempus AI, Inc. based in?
- Tempus AI, Inc. is headquartered in United States
- When did Tempus AI, Inc. go public?
- Tempus AI, Inc. initial public offering (IPO) was on June 14, 2024
- Is Tempus AI, Inc. in the S&P 500?
- No, Tempus AI, Inc. is not included in the S&P 500 index
- Is Tempus AI, Inc. in the NASDAQ 100?
- No, Tempus AI, Inc. is not included in the NASDAQ 100 index
- Is Tempus AI, Inc. in the Dow Jones?
- No, Tempus AI, Inc. is not included in the Dow Jones index
- When was Tempus AI, Inc. last earnings report?
- Tempus AI, Inc.'s most recent earnings report was on July 30, 2026
- When does Tempus AI, Inc. report earnings?
- The next expected earnings date for Tempus AI, Inc. is November 2, 2026
Data Sources & References
- TEM Official Website www.tempus.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1717115/000119312526066961/0001193125-26-066961-index.htm
- TEM Profile on Yahoo Finance finance.yahoo.com/quote/TEM
- TEM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tem